159 related articles for article (PubMed ID: 16519961)
1. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation.
Ernst A; Hellmich S; Bergmann A
Peptides; 2006 Jul; 27(7):1787-93. PubMed ID: 16519961
[TBL] [Abstract][Full Text] [Related]
2. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation.
Ernst A; Köhrle J; Bergmann A
Peptides; 2006 Jul; 27(7):1835-40. PubMed ID: 16621157
[TBL] [Abstract][Full Text] [Related]
3. Detection of stable N-terminal protachykinin A immunoreactivity in human plasma and cerebrospinal fluid.
Ernst A; Suhr J; Köhrle J; Bergmann A
Peptides; 2008 Jul; 29(7):1201-6. PubMed ID: 18374454
[TBL] [Abstract][Full Text] [Related]
4. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.
Christ-Crain M; Stoeckli R; Ernst A; Morgenthaler NG; Bilz S; Korbonits M; Struck J; Bergmann A; Müller B; Keller U
J Clin Endocrinol Metab; 2006 Sep; 91(9):3544-7. PubMed ID: 16787986
[TBL] [Abstract][Full Text] [Related]
5. Production of recombinant large proneurotensin/neuromedin N-derived peptides and characterization of their binding and biological activity.
Friry C; Feliciangeli S; Richard F; Kitabgi P; Rovere C
Biochem Biophys Res Commun; 2002 Feb; 290(4):1161-8. PubMed ID: 11811984
[TBL] [Abstract][Full Text] [Related]
6. Investigation of proNT/NMN secretion from small cell lung carcinoma cells using a mouse xenograft model.
Wakabayashi-Nakao K; Maruyama K; Ishii H; Muramatsu K; Hatakeyama K; Ohshima K; Ogura S; Nakajima T; Yamaguchi K; Mochizuki T
Oncol Rep; 2012 Oct; 28(4):1181-6. PubMed ID: 22825476
[TBL] [Abstract][Full Text] [Related]
7. Pro-neurotensin/neuromedin N and risk of ischemic stroke: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Nicoli CD; Wettersten N; Judd SE; Howard G; Howard VJ; Struck J; Cushman M
Vasc Med; 2020 Dec; 25(6):534-540. PubMed ID: 33089749
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific processing of neurotensin/neuromedin-N precursor in cat.
Carraway RE; Mitra SP; Joyce TJ
Regul Pept; 1993 Jan; 43(1-2):97-106. PubMed ID: 8426913
[TBL] [Abstract][Full Text] [Related]
9. Proneurotensin/Neuromedin N and Risk of Incident CKD and Other Kidney Outcomes in Community-Living Individuals: The REGARDS Study.
Bullen AL; Fregoso-Leyva A; Katz R; Long DL; Cheung KL; Judd SE; Gutierrez OM; Ix JH; Cushman M; Rifkin DE
Kidney Med; 2024 Jun; 6(6):100831. PubMed ID: 38774125
[TBL] [Abstract][Full Text] [Related]
10. BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing.
Carraway RE; Mitra SP; Evers BM; Townsend CM
Regul Pept; 1994 Aug; 53(1):17-29. PubMed ID: 7800856
[TBL] [Abstract][Full Text] [Related]
11. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
[TBL] [Abstract][Full Text] [Related]
12. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.
Muraki K; Mitra SP; Dobner PR; Carraway RE
Peptides; 1993; 14(6):1095-102. PubMed ID: 8134290
[TBL] [Abstract][Full Text] [Related]
14. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.
Carraway RE; Mitra SP; Feurle GE; Hacki WH
J Clin Endocrinol Metab; 1988 Jun; 66(6):1323-8. PubMed ID: 3131383
[TBL] [Abstract][Full Text] [Related]
15. Differential processing of neurotensin/neuromedin N precursor(s) in canine brain and intestine.
Carraway RE; Mitra SP
J Biol Chem; 1990 May; 265(15):8627-31. PubMed ID: 2341398
[TBL] [Abstract][Full Text] [Related]
16. Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study.
Nicoli CD; Howard VJ; Judd SE; Struck J; Manly JJ; Cushman M
J Alzheimers Dis; 2020; 76(4):1403-1412. PubMed ID: 32623400
[TBL] [Abstract][Full Text] [Related]
17. Role of proneurotensin as marker of paediatric coeliac disease.
Montén C; Torinsson Naluai Å; Agardh D
Clin Exp Immunol; 2016 Dec; 186(3):387-392. PubMed ID: 27612962
[TBL] [Abstract][Full Text] [Related]
18. The use of radioimmunoassay to compare the tissue and subcellular distributions of neurotensin and neuromedin N in the cat.
Carraway RE; Mitra SP
Endocrinology; 1987 May; 120(5):2092-100. PubMed ID: 3569126
[TBL] [Abstract][Full Text] [Related]
19. Differential processing of pro-neurotensin/neuromedin N and relationship to pro-hormone convertases.
Kitabgi P
Peptides; 2006 Oct; 27(10):2508-14. PubMed ID: 16904237
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis and posttranslational processing of the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. Effect of dexamethasone.
de Nadai F; Rovere C; Bidard JN; Laur J; Martinez J; Cuber JC; Kitabgi P
Endocrinology; 1993 Apr; 132(4):1614-20. PubMed ID: 8462460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
